Effects of catecholamines on the intramedullary pressure in the femur in rats with prednisolone-induced osteoporosis

Pharmacological Reports

Volumn 58, Issue 4, 2006, Pages 540-550

  Kaczmarczyk Sedlak, Ilona ^a   Cegieła, Urszula ^a   Nowińska, Barbara ^a   Folwarczna, Joanna ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Catecholamines; Intramedullary pressure; Osteoporosis; Prednisolone; Rat

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE DERIVATIVE; ISOPRENALINE; NORADRENALIN; PHENTOLAMINE; PREDNISOLONE; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BONE MARROW; CAROTID ARTERY; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; DRUG ACTIVITY; DRUG EFFECT; FEMUR; MALE; NONHUMAN; PRESSURE MEASUREMENT; RAT;

EID: 33748651666     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Artico M, Bosco S, Cavallotti C, Agostinelli E, Giuliani-Piccari G, Sciorio S, Cocco L et al: Noradrenergic and cholinergic innervation of the bone marrow. Int J Mol Med, 2002, 10, 77-80.
2. Basu M, Sawhney RC, Kumar S, Pal K, Prasad R, Selvamurthy W: Hypothalamic-pituitary-adrenal axis following glucocorticoid prophylaxis against acute mountain sickness. Horm Metab Res, 2002, 34, 318-324.
3. Benestad HB, Strøm-Gundersen I, Inversen PO, Haug E, Njå A: No neuronal regulation of murine bone marrow function. Blood, 1998, 91, 1280-1287.
4. Bronnegard M, Reynisdottir S, Marcus C, Stierna P, Arner P: Effect of glucocorticosteroid treatment on glucocorticoid receptor expression in human adipocytes. J Clin Endocrinol Metab, 1995, 80, 3608-3612.
5. Conrad TJ, Chandler DB, Corless JM, Klintworth GK: In vivo measurement of corneal angiogenesis with video data acquisition and computerized image analysis. Lab Invest, 1994, 70, 426-434.
6. Dabrowski Z, Tabarowski Z: History of discoveries of bone marrow and bone vascularisation and innervation. In: Bone Circulation and Vascularization in Normal and Pathological Conditions. Ed. Schoutens A, Arlet J, Gardeniers JWN, Hughes SPF, Plenum Press, New York, 1993, 49-61.
7. Di Filippo C, Rossi F, Ongini E, Del Soldato P, Perretti M, D'Amico M: The distinct alterations produced in cardiovascular functions by prednisolone and nitro-prednisolone (NCX-015) in the rat highlight a causal role for endothelin-1. J Pharmacol Exp Ther, 2004, 310, 1133-1141.
8. Ficat RP, Arlet J: Ischemia and Necrosis of Bone. Williams & Wilkins, Baltimore 1980, 196.
9. Gross PM, Heistad DD, Marcus ML: Neurohumoral regulation of blood flow to bones and marrow. Am J Physiol, 1979, 237, H440-H448.
10. Hall JE, Morse CL, Smith MJ Jr, Young DB, Guyton AC: Control of arterial pressure and renal finiction during glucocorticoid excess in dogs. Hypertension, 1980, 2, 139-148.
11. Hohmann EL, Elde RP, Rysavy JA, Einzig S, Gebhard RL: Innervation of periosteum and bone by sympathetic vasoactive intestinal peptide-containing nerve fibers. Science 1986, 232, 868-871.
12. Hughes SPF, Corbett SA, Reichert ILH, McCarthy ID: The regulation of blood flow in bone. In: Osteonecrosis. Ed. Urbaniak JR, Jones JP. Rosemont, American Academy of Orthopaedic Surgeons, 1997, 11-19.
13. Ivarsen P, Jensen LW, Pedersen EB: Circardian blood pressure rhythm and atrial natriuretic peptide in prednisolone-induced blood pressure elevation. Scan J Clin Lab Invest, 1995, 55, 655-662.
14. Jackson SH, Beevers DG, Myers K: Does long-term low-dose corticosteroid therapy cause hypertension? Clin Sci (Lond), 1981, 61, 381S-383S.
15. Janiec W: Pharmacodynamics of drugs influencing osseous system (Polish). In: Pharmacodynamics. Ed. Janiec W, Krupińska J, PZWL, Warszawa, 2002, 742-758.
16. Jones G, Sambrook Ph: Drug-induced disorders of bone metabolism. Drug Safety, 1994, 10, 480-489.
17. Kaczmarczyk-Sedlak I, Janice W: The effects of catecholamines on blood pressure in the long bone marrow cavity in rats with bisphosphonate-induced osteopetrosis. Pharmacol Rep, 2005, 57, 623-634.
18. Krakoff LF, Selvadurai R, Sutter E: Effect of methyl-prednisolone upon arterial pressure and the renin-angiotensin system in the rat. Am J Physiol, 1975, 228, 613-617.
19. Marino F, Cosentino M, Bombelli R, Ferrari M, Maestroni G, Conti A, Lecchini S, Frigo G: Measurement of catecholamines in mouse bone marrow by means of HPLC with electrochemical detection. Haematologica, 1997, 82, 392-394.
20. Moran CG, McGrory BJ, Bronk JT, Bronk JT, Wood MB: Reperfusion injury in vascularized bone allografts. J Orthop Res, 1995, 13, 368-374.
21. Moran CG, McGrory BJ, Roorda J, Wood MB: Adrenergic control mechanisms of blood flow in a vascularized canine tibial allograft. J Orthop Res, 1993, 11, 429-437.
22. Nishimura H, Yoshikawa T, Kobayashi N, Anzai T, Nagami K, Handa, S, Ogawa S: Effects of methylprednisolone on hemodynamics and beta-adrenergic receptor signaling in rabbits with acute left ventricular failure. Heart Vessels, 1997, 12, 84-91.
23. Ohkawara A, Iizuka H: Glucocorticoid-induced alteration of beta-adrenergic adenylate cyclase response of epidermis. Arch Dermatol Res, 1985, 277, 88-92.
24. Orcel P: Prevention and treatment of glucocorticoid-induced osteoporosis in 2005. Joint Bone Spine, 2005, 72, 461-465.
25. Pethig K, Heublein B, Wahlers T, Dannenberg O, Oppelt P, Haverich A: Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: infuence on inflammation and progression of intimal hyperplasia. J Heart Lung Transplant, 2004, 23, 61-66.
26. Pongratz G, Zietz B, Gluck T, Scholmerich J, Straub RH: Corticotropin-releasing factor modulates cardiovascular and pupillary autonomic reflexes in man: is there a link to inflammation-induced autonomic nervous hyperreflexia? Ann N Y Acad Sci, 2002, 966, 373-383.
27. Prasad K, Szabo L: Cardiovascular effects of orciprenaline (Alupent) inhalation and prednisolone. Adv Myocardiol, 1980, 1, 437-452.
28. Ribeiro AB, Franco RJ, Kohlmann O Jr, Marson O, Ramos OL: Etiopathogenesis of excess methylprednisolone arterial hypertension in the rat. Clin Exp Hypertens, 1981, 3, 1219-1237.
29. Sack FU, Reidenbach B, Dollner R, Schledt A, Gebhard MM, Hagl S: Influence of steroids on microvascular perfusion injury of the bowel induced by extracorporeal circulation. Ann Thorac Surg, 2001, 72, 1321-1326.
30. Saito T, Takanashi M, Gallagher E, Fuse A, Suzaki S, Inagaki O, Yamada K, Ogawa R: Corticosteroid effect on early beta-adrenergic down-regulation during circulatory shock: hemodynamic study and beta-adrenergic receptor assay. Intensive Care Med, 1995, 21, 204-210.
31. Scherrer D, Lach E, Landry Y, Gies JP: Glucocorticoid modulation of muscarinic and beta-adrenergic receptors in guinea pig lung. Fund Clin Pharmacol, 1997, 11, 111-116.
32. Tkocz-Kwiatkowska J, Kaczmarczyk-Sedlak I, Folwarczna J: Effects of pamidronate on the development of changes in bone mechanical properties and bone structure caused by the administration of prednisolone in rats. Pol J Pharmacol, 1998, 50, 253-258.
33. Whitworth JA: Adrenocorticotrophin and steroid-induced hypertension in humans. Kidney Int Suppl, 1992, 37, S34-S37.
34. Whitworth JA, Gordon D, Andrews J, Scoggins BA: The hypertensive effect of synthetic glucocorticoids in man: role of sodium and volume. J Hypertension, 1989, 7, 537-549.
35. Wilkes CH, Visscher MB: Some physiological aspects of bone marrow pressure. J Bone Joint Surg Am, 1975, 57, 49-57.